2nd Quarter - Report

BIOGEN for BIOGEN

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Changes in the Medicare Part B reimbursement system; International Pricing Index proposal; and Administration and Congressional proposal to address rebates in the Medicare Part D program.

LobbyistCovered position, as disclosed
ADAM BRAND —
SARAH CHRISTINE D'ORSIE —
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

IP protections for biologics and pharmaceuticals, consistent with U.S. law, to be included in trade agreements.

LobbyistCovered position, as disclosed
ADAM BRAND —
SARAH CHRISTINE D'ORSIE —
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Domestic and international tax policies that protect and incentivize U.S. based research and manufacturing jobs.

LobbyistCovered position, as disclosed
ADAM BRAND —
SARAH CHRISTINE D'ORSIE —
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON New —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Issues pertaining to the U.S. Patent system; Inter Partes Review process at the PTO; Patent law as it pertains to the IP system/process.

LobbyistCovered position, as disclosed
ADAM BRAND —
SARAH CHRISTINE D'ORSIE —
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Health Care Reform -The Improving Chronic Care Management Act (H.R. 3436) Biosimilars Policy (no Bill). Affordable and Safe Prescription Drug Importation Act;H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act Prescription Pricing for People Act (S. 1227/H.R. 2376) Drug Rebate regulation - (proposed rule, no Bill) Newborn Screening Programs (no Bill) Scientific and Medical Innovation (no bill) Affordable Prescriptions for Patients Act of S.1416

LobbyistCovered position, as disclosed
ADAM BRAND —
SARAH CHRISTINE D'ORSIE —
STEPHANIE A. DYSON New Deputy Office Director, OSORA CMS Special Assistant, COO, CMS
JOHN RAYMOND GIBSON New —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 1416 (116th), S. 1227 (116th), H.R. 2376 (116th), H.R. 3436 (116th), H.R. 987 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.